CSO
Prof. Shai Rahimipour, Ph.D., serves as the Chief Scientific Officer (CSO) of Apex Bio, where he leads the company’s scientific strategy and innovation pipeline in the pursuit of groundbreaking therapies for neurodegenerative diseases. With a distinguished academic background and decades of research leadership, Prof. Rahimipour is internationally recognized for his expertise in peptide chemistry, molecular biology, and the pathological mechanisms underlying Alzheimer’s and related brain disorders.
At Apex Bio, Prof. Rahimipour oversees all discovery and translational research activities, guiding multidisciplinary teams as they advance next-generation therapeutics targeting amyloid and protein aggregation pathways. His scientific vision and collaborative approach drive the development of novel drug candidates and biomarkers, positioning Apex Bio at the forefront of biotechnological innovation.
Prior to joining Apex Bio, Prof. Rahimipour held senior faculty appointments, published extensively in leading scientific journals, and mentored researchers in academic and industrial settings. He brings a track record of successful research commercialization and grant acquisition, as well as a passion for training the next generation of scientific talent.
Prof. Rahimipour’s leadership is integral to Apex Bio’s mission to transform patient outcomes and deliver meaningful advances in brain health through science-driven solutions.
